Carbohydrate vaccines in cancer: Immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man
Susan F. Slovin(Cornell University), Howard I. Scher(Memorial Sloan Kettering Cancer Center), Melissa Fazzari(Memorial Sloan Kettering Cancer Center), Kenneth O. Lloyd(Memorial Sloan Kettering Cancer Center), Philip O. Livingston(Memorial Sloan Kettering Cancer Center), Grace E. Ungers(Memorial Sloan Kettering Cancer Center), Kathryn L. Terry(Brigham and Women's Hospital), Maria Spassova(Memorial Sloan Kettering Cancer Center), Samuel J. Danishefsky(Kettering University), S. Kim(Memorial Sloan Kettering Cancer Center), Sucharita Adluri(Memorial Sloan Kettering Cancer Center), Govindaswami Ragupathi(Memorial Sloan Kettering Cancer Center), L Dantis(Memorial Sloan Kettering Cancer Center), W. G. BORNMANN(Memorial Sloan Kettering Cancer Center), Krystyna M. Olkiewicz(Memorial Sloan Kettering Cancer Center)
Cited by 253
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k